InspireMD (NSPR) Tops Q4 EPS by 4c

InspireMD (NASDAQ: NSPR) reported Q4 EPS of ($0.16), $0.04 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $1.76 million versus the consensus estimate of $1.63 million.

For earnings history and earnings-related data on InspireMD (NSPR) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• MP Materials seen largely insulated after China export-control move